AMANDA BRAZIER: Open Payments
NPI 1104520683 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 42 payments from 12 companies in 2025. Trend: 2023 $587 · 2024 $332 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $280 |
| AstraZeneca Pharmaceuticals LP | 6 | $175 |
| Exact Sciences Corporation | 4 | $78 |
| Novo Nordisk Inc | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, BREZTRI, GLASSIA, QULIPTA, Ozempic, FARXIGA, AUSTEDO XR, Cologuard Collection Kit.
Industry payments across NM — which companies pay providers there.
